Purdue Pharma settles Oklahoma opioid case

Two Purdue Pharma lawyers walk past protestors outside a courthouse.
Families protest as Purdue Pharma lawyers enter the courthouse for a status update in the case. Photo: Suzanne Kreiter/The Boston Globe via Getty Images

Purdue Pharma, the producer of OxyContin, settled a lawsuit on Tuesday brought by the state of Oklahoma alleging that the company made billions of dollars while fueling the country's opioid crisis, reports Bloomberg.

The big picture: Purdue was set to go to trial in Oklahoma in May, along with fellow opioid manufacturers Johnson & Johnson and Teva. The settlement only covers the claims against Purdue, which agreed to pay $270 million with the help of its owners, the Sackler family, per the Wall Street Journal. The outcome of the Oklahoma case was largely viewed as a bellwether for a much larger, consolidated national opioids lawsuit underway in Ohio.

Go deeper: Where the national opioids lawsuit could be headed

Purdue Pharma says cameras will create "media circus" in opioid trial

A bottle of oxycodone pills on a table.
Purdue Pharma makes oxycodone pills under the brand name OxyContin. Photo: Education Images/UIG via Getty Images

Purdue Pharma is asking an Oklahoma court to ban all video cameras from the company's upcoming trial, arguing the filming would inappropriately influence jurors and witnesses, and would create a "media circus." Law360 first reported Purdue's motion.

Why it matters: The Oklahoma case is the first major legal battle between public officials and the companies involved with making, distributing and selling prescription painkillers — and the industry wants the case to be in as controlled an environment as possible.